LuciBriga 180mg (Brigatinib)

Description

LuciBriga 180mg (Brigatinib) is a targeted cancer medicine used to treat ALK-positive metastatic non-small cell lung cancer (NSCLC). It works by blocking the abnormal ALK protein, which helps slow or stop the growth of cancer cells.

Dosage:
Treatment usually starts with 90 mg once daily for the first 7 days, then increased to 180 mg once daily, depending on the doctor’s recommendation. LuciBriga 180mg (Brigatinib) can be taken with or without food, or as directed by a healthcare professional.

Side Effects

Some patients using LuciBriga 180mg (Brigatinib) may experience:

• Nausea
• Fatigue
• Diarrhea
• Headache
• Cough

In rare cases, LuciBriga 180mg may cause serious side effects such as lung inflammation, high blood pressure, or vision problems. Patients should contact a doctor if severe symptoms appear.

Prescribing Information

Before starting treatment, doctors usually confirm the ALK gene mutation through diagnostic testing. LuciBriga 180mg (Brigatinib) should only be used under the supervision of an experienced healthcare professional.

Patients should inform their doctor about other medications and avoid using LuciBriga 180mg during pregnancy or breastfeeding.

Suggestion

For best results, take LuciBriga 180mg (Brigatinib) exactly as prescribed. Do not change the dose or stop treatment without medical advice. Regular monitoring and follow-up visits are recommended during treatment.

FAQ

Is LuciBriga 180mg effective if other lung cancer treatments stop working?
Yes. LuciBriga 180mg (Brigatinib) is often prescribed for patients with ALK-positive NSCLC, including those who may have previously received other targeted therapies.

How long does LuciBriga treatment usually continue?
Treatment with LuciBriga 180mg typically continues as long as the medicine is controlling the cancer and side effects remain manageable.

What should I do if I miss a dose of LuciBriga 180mg?
If you miss a dose, take the next scheduled dose at the regular time. Do not take a double dose to make up for the missed one.